203 related articles for article (PubMed ID: 9815931)
1. Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft.
Tamura S; Ouchi KF; Mori K; Endo M; Matsumoto T; Eda H; Tanaka Y; Ishitsuka H; Tokita H; Yamaguchi K
Clin Cancer Res; 1995 Nov; 1(11):1353-8. PubMed ID: 9815931
[TBL] [Abstract][Full Text] [Related]
2. Comparison of animal models for head and neck cancer cachexia.
Cannon T; Couch M; Yin X; Guttridge D; Lai V; Shores C
Laryngoscope; 2007 Dec; 117(12):2152-8. PubMed ID: 17921906
[TBL] [Abstract][Full Text] [Related]
3. Role of cytokines in cancer cachexia in a murine model of intracerebral injection of human tumours.
Negri DR; Mezzanzanica D; Sacco S; Gadina M; Benigni F; Cajola L; Finocchiaro G; Ghezzi P; Canevari S
Cytokine; 2001 Jul; 15(1):27-38. PubMed ID: 11509006
[TBL] [Abstract][Full Text] [Related]
4. Experimental cancer cachexia: the role of host-derived cytokines interleukin (IL)-6, IL-12, interferon-gamma, and tumor necrosis factor alpha evaluated in gene knockout, tumor-bearing mice on C57 Bl background and eicosanoid-dependent cachexia.
Cahlin C; Körner A; Axelsson H; Wang W; Lundholm K; Svanberg E
Cancer Res; 2000 Oct; 60(19):5488-93. PubMed ID: 11034092
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice.
Yasumoto K; Mukaida N; Harada A; Kuno K; Akiyama M; Nakashima E; Fujioka N; Mai M; Kasahara T; Fujimoto-Ouchi K
Cancer Res; 1995 Feb; 55(4):921-7. PubMed ID: 7850809
[TBL] [Abstract][Full Text] [Related]
6. Role of endogenous tumor necrosis factor alpha and interleukin 1 for experimental tumor growth and the development of cancer cachexia.
Gelin J; Moldawer LL; Lönnroth C; Sherry B; Chizzonite R; Lundholm K
Cancer Res; 1991 Jan; 51(1):415-21. PubMed ID: 1703040
[TBL] [Abstract][Full Text] [Related]
7. Prevention of adenocarcinoma colon 26-induced cachexia by interleukin 10 gene transfer.
Fujiki F; Mukaida N; Hirose K; Ishida H; Harada A; Ohno S; Bluethmann H; Kawakami M; Akiyama M; Sone S; Matsushima K
Cancer Res; 1997 Jan; 57(1):94-9. PubMed ID: 8988047
[TBL] [Abstract][Full Text] [Related]
8. [Role of NF-kappa B in cancer cachexia].
Zhou W; Jiang ZW; Jiang J; Li N; Li JS
Zhonghua Wai Ke Za Zhi; 2004 Jun; 42(11):683-6. PubMed ID: 15329260
[TBL] [Abstract][Full Text] [Related]
9. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
[TBL] [Abstract][Full Text] [Related]
10. Clodronate alleviates cachexia and prolongs survival in nude mice xenografted with an anaplastic thyroid carcinoma cell line.
Wang CH; Shen YC; Hsieh JJ; Yeh KY; Chang JW
J Endocrinol; 2006 Aug; 190(2):415-23. PubMed ID: 16899574
[TBL] [Abstract][Full Text] [Related]
11. Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann G; Fong M; Kenney JS; Jacob CO
J Clin Invest; 1992 May; 89(5):1681-4. PubMed ID: 1569207
[TBL] [Abstract][Full Text] [Related]
12. Tumour inoculation site-dependent induction of cachexia in mice bearing colon 26 carcinoma.
Matsumoto T; Fujimoto-Ouchi K; Tamura S; Tanaka Y; Ishitsuka H
Br J Cancer; 1999 Feb; 79(5-6):764-9. PubMed ID: 10070867
[TBL] [Abstract][Full Text] [Related]
13. Selective up-regulation of tumor necrosis factor receptor I in tumor-bearing rats with cancer-related cachexia.
Catalano MG; Fortunati N; Arena K; Costelli P; Aragno M; Danni O; Boccuzzi G
Int J Oncol; 2003 Aug; 23(2):429-36. PubMed ID: 12851692
[TBL] [Abstract][Full Text] [Related]
14. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome in nude mice bearing human melanomas G361 and SEKI.
Kawamura I; Lacey E; Inami M; Nishigaki F; Naoe Y; Tsujimoto S; Manda T; Goto T
Anticancer Res; 1999; 19(5B):4091-7. PubMed ID: 10628359
[TBL] [Abstract][Full Text] [Related]
15. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.
Strassmann G; Fong M; Freter CE; Windsor S; D'Alessandro F; Nordan RP
J Clin Invest; 1993 Nov; 92(5):2152-9. PubMed ID: 8227330
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a cancer cachectic factor.
Todorov P; Cariuk P; McDevitt T; Coles B; Fearon K; Tisdale M
Nature; 1996 Feb; 379(6567):739-42. PubMed ID: 8602222
[TBL] [Abstract][Full Text] [Related]
17. Capecitabine improves cancer cachexia and normalizes IL-6 and PTHrP levels in mouse cancer cachexia models.
Fujimoto-Ouchi K; Onuma E; Shirane M; Mori K; Tanaka Y
Cancer Chemother Pharmacol; 2007 May; 59(6):807-15. PubMed ID: 17009035
[TBL] [Abstract][Full Text] [Related]
18. Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice.
Tanaka K; Urata N; Mikami M; Ogasawara M; Matsunaga T; Terashima N; Suzuki H
Inflamm Res; 2007 Jan; 56(1):17-23. PubMed ID: 17334666
[TBL] [Abstract][Full Text] [Related]
19. Neutralizing antibodies to human interleukin 6 reverse hypercalcemia associated with a human squamous carcinoma.
Yoneda T; Nakai M; Moriyama K; Scott L; Ida N; Kunitomo T; Mundy GR
Cancer Res; 1993 Feb; 53(4):737-40. PubMed ID: 8428354
[TBL] [Abstract][Full Text] [Related]
20. In vivo gene transfer of murine interleukin-4 inhibits colon-26-mediated cancer cachexia in mice.
Sturlan S; Beinhauer BG; Oberhuber G; Huang L; Aasen AO; Rogy MA
Anticancer Res; 2002; 22(5):2547-54. PubMed ID: 12529962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
